Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's desease
- 31 December 1994
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 55 (25-26), 2077-2082
- https://doi.org/10.1016/0024-3205(94)00388-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The possible role of iron in the etiopathology of parkinson's diseaseMovement Disorders, 1993
- The oxidant stress hypothesis in Parkinson's disease: Evidence supporting itAnnals of Neurology, 1992
- A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTPThe FASEB Journal, 1992
- Brain iron and ferritin in Parkinson's and Alzheimer's diseasesJournal of Neural Transmission, 1990
- Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?Acta Neurologica Scandinavica, 1989
- Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brainsNeurology, 1988
- Production of superoxide anions by a CNS macrophage, the microgliaFEBS Letters, 1987
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASEThe Lancet, 1977
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal of Neural Transmission, 1975